SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-22-119360
Filing Date
2022-11-16
Accepted
2022-11-16 08:28:21
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 tm2230623-1_424b3.htm 424B3 454817
2 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 22590
3 GRAPHIC tm2230623d1-fc_devl4clr.jpg GRAPHIC 59127
4 GRAPHIC tm2230623d1-fc_early4clr.jpg GRAPHIC 97626
5 GRAPHIC tm2230623d1-fc_outlic4clr.jpg GRAPHIC 57412
6 GRAPHIC tm2230623d1-fc_resrh4clr.jpg GRAPHIC 129072
  Complete submission text file 0001104659-22-119360.txt   960419
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-266995 | Film No.: 221393046
SIC: 2834 Pharmaceutical Preparations